USP7 and neoplasm: For example, the tumour suppressor protein p53 was the first identified deubiquitination substrate for USP7, this attributed to USP7 as a tumour suppressor, given its ability to increase the stability of p53, resulting in repression of cancer cell growth and activation of apoptotic pathways.21